CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The DRIVE-AB project addresses the growing issue of antimicrobial resistance by developing new economic models and strategies to incentivize the discovery of novel antibiotics. It aims to balance the need for responsible antibiotic use with the financial viability of drug development through collaboration among diverse…
Antimicrobial resistance (AMR) is widespread.
Its global human and economic burden is tremendous and increasing annually.
Yet today only a few pharmaceutical companies retain active antibacterial drug discovery programmes.
While the elaboration of antibiotics with novel mechanisms of action is scientifically complex, the chief challenge is diminishing incentives.
Pre-market regulatory requirements and increased control on post-market access, use, and pricing of new antibiotics are strong deterre…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Switzerland, Geneve
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Belgium, Antwerpen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
STICHTING RADBOUD UNIVERSITEIT
Netherlands, Nijmegen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Sweden, Uppsala
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
